The pharma reported a multi-fold jump in consolidated net profit at Rs 107.59 crore for the second quarter ended September 30, mainly on account of robust sales and lower tax expense.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
